By: Benzinga
February 08, 2013 at 07:27 AM EST
Benzinga's Top Downgrades
Analysts at Canaccord downgraded Teva Pharmaceutical Industries (NYSE: TEVA ) from “buy” to “hold.” The target price for Teva has been raised from $50 to $45. Teva's shares closed at $37.96 yesterday. Analysts at FBR Capital downgraded Riverbed Technology (NASDAQ: RVBD ) from “outperform” to “market perform.” The
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here